Kalia LV, Lang AE (2015) Parkinson’s disease. Lancet 386:896–912

Article  CAS  PubMed  Google Scholar 

Braak H, Tredici KD, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211

Article  PubMed  Google Scholar 

Braak H, Rüb U, Gai WP, Del Tredici K (1996) Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm Vienna Austria 2003(110):517–536

Google Scholar 

Li J, Mestre TA, Mollenhauer B, Frasier M, Tomlinson JJ, Trenkwalder C et al (2022) Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examination. Npj Park Dis 8:1–12

Google Scholar 

Smeyne RJ, Noyce AJ, Byrne M, Savica R, Marras C (2021) Infection and risk of Parkinson’s disease. J Park Dis 11:31–43

CAS  Google Scholar 

Al-Aly Z, Xie Y, Bowe B (2021) High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594:259–264

Article  CAS  PubMed  Google Scholar 

Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R (2020) Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis. Mayo Clin Proc 95:1621–1631

Article  CAS  PubMed  Google Scholar 

Sayin İ, Yaşar KK, Yazici ZM (2020) Taste and smell impairment in COVID-19: an AAO-HNS anosmia reporting tool-based comparative study. Otolaryngol-Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 163:473–479

Article  Google Scholar 

Lechien JR, Chiesa-Estomba CM, Beckers E, Mustin V, Ducarme M, Journe F et al (2021) Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med 290:451–461

Article  CAS  PubMed  Google Scholar 

Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, Geisthoff UW, Bauer C, Hautefort C et al (2020) Smell and taste dysfunction in patients with COVID-19. Lancet Infect Dis 20:1015–1016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Serrano GE, Walker JE, Tremblay C, Piras IS, Huentelman MJ, Belden CM et al (2022) SARS-CoV-2 brain regional detection, histopathology, gene expression, and immunomodulatory changes in decedents with COVID-19. J Neuropathol Exp Neurol 81:666–695

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R et al (2021) Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 24:168–175

Article  CAS  PubMed  Google Scholar 

Khan M, Yoo S-J, Clijsters M, Backaert W, Vanstapel A, Speleman K et al (2021) Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell 184:5932-5949.e15

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zazhytska M, Kodra A, Hoagland DA, Frere J, Fullard JF, Shayya H et al (2022) Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell 185:1052-1064.e12

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ho C-Y, Salimian M, Hegert J, O’Brien J, Choi SG, Ames H et al (2022) Postmortem assessment of olfactory tissue degeneration and microvasculopathy in patients with COVID-19. JAMA Neurol 79:544–553

Article  PubMed  PubMed Central  Google Scholar 

Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P et al (2022) SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 604:697–707

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tomlinson JJ, Shutinoski B, Dong L, Meng F, Elleithy D, Lengacher NA et al (2017) Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects. J Neural Transm 124:721–738

Article  CAS  PubMed  Google Scholar 

Käufer C, Schreiber CS, Hartke A-S, Denden I, Stanelle-Bertram S, Beck S, et al. Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. eBioMedicine [Internet]. 2022 [cited 2023 Mar 30]; 79. Available from: https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(22)00183-9/fulltext

Philippens IHCHM, Böszörményi KP, Wubben JAM, Fagrouch ZC, van Driel N, Mayenburg AQ et al (2022) Brain inflammation and intracellular α-Synuclein aggregates in macaques after SARS-CoV-2 infection. Viruses 14:776

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iravanpour F, Farrokhi MR, Jafarinia M, Oliaee RT (2023) The effect of SARS-CoV-2 on the development of Parkinson’s disease: the role of α-synuclein. Hum Cell 37:1–8

Article  PubMed  Google Scholar 

Tavassoly O, Safavi F, Tavassoly I (2020) Seeding brain protein aggregation by SARS-CoV-2 as a possible long-term complication of COVID-19 infection. ACS Chem Neurosci 11:3704–3706

Article  CAS  PubMed  Google Scholar 

Bhardwaj T, Gadhave K, Kapuganti SK, Kumar P, Brotzakis ZF, Saumya KU et al (2023) Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes. Nat Commun 14:945

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beatman EL, Massey A, Shives KD, Burrack KS, Chamanian M, Morrison TE et al (2015) Alpha-synuclein expression restricts rna viral infections in the brain. J Virol 90:2767–2782

Article  PubMed  Google Scholar 

Brundin P, Nath A, Beckham JD (2020) Is COVID-19 a perfect storm for Parkinson’s disease? Trends Neurosci 43:931–933

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cohen ME, Eichel R, Steiner-Birmanns B, Janah A, Ioshpa M, Bar-Shalom R et al (2020) A case of probable Parkinson’s disease after SARS-CoV-2 infection. Lancet Neurol 19:804–805

Article  CAS  PubMed  PubMed Central  Google Scholar 

Faber I, Brandão PRP, Menegatti F, de Carvalho Bispo DD, Maluf FB, Cardoso F (2020) Coronavirus disease 2019 and Parkinsonism: a non-post-encephalitic case. Mov Disord Off J Mov Disord Soc 35:1721–1722

Article  CAS  Google Scholar 

Méndez-Guerrero A, Laespada-García MI, Gómez-Grande A, Ruiz-Ortiz M, Blanco-Palmero VA, Azcarate-Diaz FJ et al (2020) Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology 95:e2109–e2118

Article  PubMed  Google Scholar 

Leta V, Rodríguez-Violante M, Abundes A, Rukavina K, Teo JT, Falup-Pecurariu C et al (2021) Parkinson’s disease and post-COVID-19 syndrome: the Parkinson’s Long-COVID spectrum. Mov Disord Off J Mov Disord Soc 36:1287–1289

Article  CAS  Google Scholar 

Wang L, Davis PB, Volkow ND, Berger NA, Kaelber DC, Xu R (2022) Association of COVID-19 with new-onset Alzheimer’s disease. J Alzheimers Dis 89:411–414

Article  CAS  PubMed  PubMed Central  Google Scholar 

Radzun HJ, Hansmann ML, Heidebrecht HJ, Bödewadt-Radzun S, Wacker HH, Kreipe H et al (1991) Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1P. Lab Investig J Tech Methods Pathol 65:306–315

CAS  Google Scholar 

Allan C, Burel J-M, Moore J, Blackburn C, Linkert M, Loynton S et al (2012) OMERO: flexible, model-driven data management for experimental biology. Nat Methods 9:245–253

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paulus W, Roggendorf W, Kirchuer T (1992) Ki-M1P as a marker for microglia and brain macrophages in routinely processed human tissues. Acta Neuropathol (Berl) 84:538–544

Article  CAS  PubMed  Google Scholar 

Gawish R, Starkl P, Pimenov L, Hladik A, Lakovits K, Oberndorfer F et al (2022) ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology. elife 11:e74623

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levine KS, Leonard HL, Blauwendraat C, Iwaki H, Johnson N, Bandres-Ciga S et al (2023) Virus exposure and neurodegenerative disease risk across national biobanks. Neuron 111:1086-1093.e2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rahmati M, Udeh R, Yon DK, Lee SW, Dolja-Gore X, McEVoy M et al (2023) A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: a call to action for neurological, physical, and psychological sciences. J Med Virol 95:e28852

Article  CAS  PubMed  Google Scholar 

Rahmati M, Yon DK, Lee SW, Soysal P, Koyanagi A, Jacob L et al (2023) New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: a systematic review and meta-analysis. J Med Virol 95:e28909

Article  CAS  PubMed  Google Scholar 

Besteher B, Machnik M, Troll M, Toepffer A, Zerekidze A, Rocktäschel T et al (2022) Larger gray matter volumes in neuropsychiatric long-COVID syndrome. Psychiatry Res 317:114836

Article  PubMed